Literature DB >> 7188317

Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates.

J D Elsworth, D E Redmond, R H Roth.   

Abstract

The relationship between MHPG concentration in several brain areas, cisternal CSF and plasma was examined in 26 vervet monkeys. Free MHPG was measured by gas chromatography-mass spectrometry using deuterated MHPG as internal standard. In animals with or without treatment with drugs that alter norepinephrine metabolism, highly significant correlations were found in concentrations of MHPG between the various brain areas, between plasma and CSF, between plasma and brain areas and between CSF and brain areas. The concentration of MHPG in CSF was higher than in plasma and with the exception of occipital cortex, all brain regions contained a higher concentration of MHPG than CSF. This study supports the notion that free MHPG concentrations in plasma and cisternal CSF are useful indices of central noradrenergic activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7188317     DOI: 10.1016/0006-8993(82)90200-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Effects of yohimbine in obsessive compulsive disorder.

Authors:  S A Rasmussen; W K Goodman; S W Woods; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 2.  Systems biology of the vervet monkey.

Authors:  Anna J Jasinska; Christopher A Schmitt; Susan K Service; Rita M Cantor; Ken Dewar; James D Jentsch; Jay R Kaplan; Trudy R Turner; Wesley C Warren; George M Weinstock; Roger P Woods; Nelson B Freimer
Journal:  ILAR J       Date:  2013

3.  Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.

Authors:  B Scatton; H Loo; T Dennis; C Benkelfat; C Gay; M F Poirier-Littre
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Raised plasma concentrations of 3-methoxy-4-hydroxyphenylethyleneglycol in cirrhotic patients with or without hepatic encephalopathy.

Authors:  H Echizen; A Minegishi; S Hayashi; N Umeda; T Oda; T Ishizaki
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

5.  Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients.

Authors:  L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study.

Authors:  Joachim Cordes; Kai G Kahl; Christian Werner; Uwe Henning; Gunnar Regenbrecht; Rolf Larisch; Christian Schmidt-Kraepelin; Johanna Thünker; Marcus W Agelink; Stefan Löffler; Thomas Hohlfeld; Wolfgang Gaebel; Ansgar Klimke
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-15       Impact factor: 5.270

7.  Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.

Authors:  M K Lakshmana; B S Rao; N K Dhingra; R Ravikumar; S Sudha; B L Meti; T R Raju
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

8.  Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.

Authors:  J H Krystal; C J McDougle; S W Woods; L H Price; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates.

Authors:  J D Elsworth; D J Leahy; R H Roth; D E Redmond
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

10.  Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis.

Authors:  Jana Janssens; Yannick Vermeiren; Erik Fransen; Tony Aerts; Debby Van Dam; Sebastiaan Engelborghs; Peter P De Deyn
Journal:  Alzheimers Dement (Amst)       Date:  2018-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.